Lv4
624 积分 2025-06-26 加入
Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial
11天前
已完结
Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders
1个月前
已关闭
Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders
1个月前
已完结
Feasibility of One-Day PET/CT Scanning Protocol with 68Ga-DOTA-FAPI-04 and 18F-FDG for the Detection of Ovarian Cancer Recurrence and Metastasis
1个月前
已完结
Clinical Cytokine Assays Early in the Course of Cytokine Release Syndrome (CRS) after CAR-T Therapy Show Difference Among Patients with Severe CRS Versus Immune Effector Cell-Associated Hemophagocytic Syndrome (IEC-HS)
4个月前
已完结
How I treat HLH-like toxicities after immune effector cell therapy
4个月前
已关闭
Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial
5个月前
已完结
Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial
5个月前
已完结
Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial
5个月前
已完结
Engineering challenges and translational opportunities in emerging gene delivery platforms
6个月前
已完结